Louis Matis Net Worth & Insider Trades

Louis Matis - Chief Development Officer, Pieris Pharmaceuticals, Inc

As of February 28, 2019

What is Louis Matis's Net Worth?

The current estimated net worth of Pieris Pharmaceuticals, Inc's Chief Development Officer, Louis Matis, is estimated to be about $18.1K . Louis Matis owns about 10,000 units of Pieris Pharmaceuticals, Inc common stock. In the last 4 years at Pieris Pharmaceuticals, Inc, Louis Matis has sold an estimated value of $0 worth.

What is Louis Matis's Past Insider Trading?

Louis Matis's largest purchase order was 10,000 units , worth over $17.04K on June 15, 2016. In total, Louis Matis has made about 5 transactions over 4 years of their time at Pieris Pharmaceuticals, Inc. Louis Matis usually trades in February, with the busiest year in 2016, 2015, 2017, 2018 and 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Louis Matis's' Mailing Address?

  • Mailing address is Lise-Meitner-Strasse 30 C/o Pieris Pharmaceuticals, Inc. Freising-Weihenstephan 2M 85354 Germany

Pieris Pharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Stephen S. Yoder 2020 $535,000 $808,699 $173,875 $21,255 $1,538,829
Stephen S. Yoder 2019 $515,000 $815,670 $208,575 $54,353 $1,593,598
Hitto Kaufmann, Ph.D.* 2020 $330,583 $86,646 $107,143 $20,958 $545,330
Hitto Kaufmann, Ph.D.* 2019 $108,176 $956,299 $36,804 - $1,101,279
Thomas Bures 2020 $283,250 $154,038 $65,856 $11,400 $514,544
Thomas Bures 2019 $257,500 $152,938 $66,242 - $476,680
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1583648/000158364821000015/pirs2021proxystatement.htm

What are Pieris Pharmaceuticals, Inc's Past Insider Trades?

Pieris Pharmaceuticals, Inc's most recent insider trade came on May 16, 2022 by Tim Demuth who bought 6,000 units worth $10.26K . In the last 7 years, insiders at Pieris Pharmaceuticals, Inc have sold an estimated value of $25.85M and bought an estimated value of $3.65M worth of shares. Insider trading is most common in January, with the busiest year in 2017. The most active traders at the company are Michael Richman, Director,  Quang Chau Khuong,  and Christopher Kiritsy, Director .

PIERIS PHARMACEUTICALS, INC. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1